The Endocrine Society hosts educational sessions to inform journalists as they research complex and emerging hormone health topics. Contact [email protected] for more information.
Anti-Obesity Medications and Compounding Concerns
November 14, 2024|
Presenters Caroline Apovian, M.D., F.A.C.P., of Brigham and Women's Hospital and Harvard Medical School in Boston, Mass., and Maria Daniela Hurtado Andrade of the Mayo Clinic in Jacksonville, Fla., explained the importance of prescribing FDA-approved medications to treat obesity.
The Truth About Hormone Balancing
January 24, 2024|
Society member Deena Adimoolam, M.D., discussed social media claims that ‘hormone balancing’ can improve health.
Obesity Treatments and Heart Health
November 9, 2023 |
Presenters Srividya Kidambi, MD, Jaime Almandoz, MD, and our Chief Medical Officer Robert W. Lash, MD, discussed how anti-obesity medications and bariatric surgery can treat obesity and improve cardiometabolic health.
The Changing Obesity Landscape
February 7, 2023 |
Presenters Ro Pereira, MD, of Denver Health Medical Center and the University of Colorado in Denver, Colo., Amy Rothberg, MD, PhD, of the University of Michigan in Ann Arbor, Mich., Michael Weintraub, MD, of NYU Langone Health and NYU Grossman School of Medicine in New York City, and Endocrine Society Chief Medical Officer Robert W. Lash, MD. discussed how a new generation of anti-obesity medications are affecting treatment.
COVID-19 and the Future of Obesity, Diabetes Care
March 29, 2022 |
Presenters Amy Rothberg, MD, PhD, of the University of Michigan in Ann Arbor, Mich.; and Mihail Zilbermint, MD, of the Johns Hopkins Community Physicians at Suburban Hospital in Bethesda, Md., discuss how COVID-19 affects obesity and diabetes treatment. The Virtual Science Writers Conference addresses topics such as how COVID-19 has exacerbated the obesity pandemic and the rise in newly diagnosed cases of diabetes in individuals who had COVID-19.
Five Harmful Chemicals to Watch Out for in Plastics
December 15, 2020 |
Presenters: Jodi Flaws, Ph.D., University of Illinois at Urbana-Champaign, U.S.; Pauliina Damdimopoulou, Ph.D., Karolinska Institutet in Stockholm, Sweden; and Sara Brosché, Ph.D., IPEN, discuss findings in a new report, “Plastics, EDCs, & Health,” from Endocrine Society and IPEN (International Pollutants Elimination Network). Plastics contain and leach hazardous chemicals, including endocrine-disrupting chemicals (EDCs) that threaten human health. The report describes a wealth of evidence supporting direct cause-and-effect links between the toxic chemical additives in plastics and specific health impacts to the endocrine system. Read the report.
State of the Science on PFAS Chemicals
October 3, 2019 |
Presenters: Scott Belcher, PhD, Endocrine Society spokesman and Professor at North Carolina State University in Raleigh, N.C., and Tasha Stoiber, Ph.D., Senior Scientist at the Environmental Working Group Policymakers are wrestling with how to address “forever” chemicals contaminating water supplies near hundreds of military sites and elsewhere across the country, which could cost billions to clean up. Experts discussed exactly what these chemicals—known as per- and polyfluoroalkyl substances (PFAS)—are and how they threaten our health.
Is BPA Safe? An Endocrine Society Virtual News Conference
October 24, 2018 |
Presenters: Laura N. Vandenberg, PhD, and Heather Patisaul, PhD
Endocrine-disrupting chemical experts explored the threat BPA poses and the growing body of scientific evidence it harms health. Despite this evidence, the U.S. Food and Drug Administration (FDA) asserted that BPA is safe for use in food packaging, based on an initial report conducted as part of the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA).
Virtual News Conference on Treatment of Symptoms of Menopause: An Endocrine Society Clinical Practice Guideline
October 7, 2015 |
Presenter: Cynthia A. Stuenkel, MD
Dr. Stuenkel discussed key recommendations from the Clinical Practice Guideline on treatments for hot flashes, night sweats, and other menopausal symptoms. The guideline encourages tailoring treatments to suit a woman’s individual symptoms, health history and preferences.
Release of Executive Summary to EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-disrupting Chemicals
September 28, 2015 |
Presenter: Andrea C. Gore, PhD
Dr. Gore discussed emerging evidence that ties endocrine-disrupting chemical exposure to two of the biggest public health threats facing society – diabetes and obesity. The statement builds upon the Society’s groundbreaking 2009 report, which examined the state of scientific evidence on endocrine-disrupting chemicals (EDCs) and the risks posed to human health. In the ensuing years, additional research has found that exposure is associated with increased risk of developing diabetes and obesity. Mounting evidence also indicates EDC exposure is connected to infertility, hormone-related cancers, neurological issues and other disorders.
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
January 15, 2015 |
Presenter: Caroline M. Apovian, MD
Dr. Apovian shared highlights from the Society's newly released Clinical Practice Guideline on the use of prescription drugs to manage obesity. Developed by Endocrine Society obesity experts, the guideline provided recommendations on when and how to use prescription drugs to promote weight loss. The guideline also addressed the effect prescription medications for other conditions can have on weight.
The Science of Sex
February 7, 2014 |
Presenters: Nanette Santoro, MD and Bradley Anawalt, MD
Drs. Santoro and Anawalt discussed how the endocrine system’s inner workings influence romantic behavior. The speakers addressed the effects of the hormones prolactin, oxytocin, estrogen and testosterone on love and lust.
2013
Endocrine-Disrupting Chemicals
April 12, 2013 |
Presenter: R. Thomas Zoeller, MS, PhD
Dr. Zoeller examines what endocrine-disrupting chemicals are, how widespread they are in the environment and the impact they have on hormones. Dr. Zoeller discusses efforts by public health groups and policymakers to reduce the health risks posed by exposure.
Growth Hormone and Anti-Aging
Feb. 22, 2013 |
Presenter: Mark Molitch, MD
Dr. Molitch discusses what growth hormone is, when doctors may prescribe growth hormone treatment, and whether or not growth hormone use provides anti-aging effects.
Pediatric Obesity
Oct. 26, 2012 |
Presenters: Robert Lustig, MD and Richard Atkinson, MD
Drs. Lustig and Atkinson address the causes of the childhood obesity epidemic. Are sugars and high fructose corn syrup to blame, or does childhood obesity trace its roots to maternal health before, during and just after pregnancy?
